Verily and Novartis Halt Glucose Detection Lens Work
Nov 20, 2018 @ 10:33

The Mountain View, CA-based company isn’t out of diabetes completely, as it still has partnerships in the space with DexCom, Sensile, and Sanofi. “Our clinical work on the glucose-sensing lens demonstrated that there was insufficient consistency in our measurements of the correlation between tear glucose and blood glucose concentrations to support the requirements of a medical device,”

Sourced through from:

Leave a Reply